These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088 [TBL] [Abstract][Full Text] [Related]
30. Haematoidin in chronic myelomonocytic leukaemia during irregular treatment with hydroxycarbamide. Zhang X; Tao C; Long F Br J Haematol; 2024 May; 204(5):1569-1570. PubMed ID: 38528621 [No Abstract] [Full Text] [Related]
31. Chronic urticaria associated with chronic myelomonocytic leukemia. Alonso R; Cisteró-Bahíma A; Enrique E; Besses C J Investig Allergol Clin Immunol; 2000; 10(6):380-1. PubMed ID: 11206941 [TBL] [Abstract][Full Text] [Related]
32. Chronic myelomonocytic leukaemia associated with acquired haemophilia A: case report and literature review. Liang Y; Lu RN; Wang R; Zhang JF; Su W; Li JY; Zhang SJ; Lu H Haemophilia; 2015 Jul; 21(4):e341-3. PubMed ID: 25982484 [No Abstract] [Full Text] [Related]
33. The management of tumor lysis syndrome. Rampello E; Fricia T; Malaguarnera M Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389 [TBL] [Abstract][Full Text] [Related]
34. Tumor lysis syndrome and neuroblastoma. Milano GM; De Sio L; Cozza R; Donfrancesco A Med Pediatr Oncol; 2003 Dec; 41(6):592. PubMed ID: 14595729 [No Abstract] [Full Text] [Related]
35. Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia. Quintas-Cardama A; Kantarjian H; O'Brien S; Jabbour E; Giles F; Ravandi F; Faderl S; Pierce S; Shan J; Verstovsek S; Cortes J Cancer; 2006 Oct; 107(7):1525-9. PubMed ID: 16955510 [TBL] [Abstract][Full Text] [Related]